From: A micro-elimination approach to addressing hepatitis C in Turkey
2015 | 2030 | |
---|---|---|
Total viremic infections | ||
Base | 278,000 | 177,000 |
Increased treatment | 278,000 | 142,000 |
WHO targets | 278,000 | 52,000 |
Prevalent Decompensated cirrhosis | ||
Base | 1500 | 1300 |
Increased treatment | 1500 | 700 |
WHO targets | 1500 | 290 |
Prevalent Hepatocellular carcinoma | ||
Base | 990 | 750 |
Increased treatment | 990 | 320 |
WHO targets | 990 | 170 |
Liver-related deaths | ||
Base | 1000 | 900 |
Increased treatment | 1000 | 530 |
WHO targets | 1000 | 200 |